U
Unicycive Therapeutics D
D
UNCY
0.58990
USD
0.04
(7.20%)
مغلق
حجم التداول
8,995
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
55,660,729
المقالات
العنوان: Unicycive Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.